The Implications Of The New EU HTA Regulation For Companies
Joint Clinical Assessments Will Become A Key Part Of The New Environment
Legal and industry expert Alexander Natz sets out key questions and answers to help companies prepare for new EU regulations on health technology assessments, one of the biggest developments to affect the pharmaceutical industry in over a decade.
